Progenics Pharmaceuticals Company Profile (NASDAQ:PGNX)

About Progenics Pharmaceuticals

Progenics Pharmaceuticals, Inc. is engaged in developing medicines and other products for targeting and treating cancer. The Company's products in development include therapeutic agents designed to target cancer and imaging agents, which focuses on enabling clinicians and patients to accurately visualize and manage their diseases. The Company's EXINI Bone BSI is an analytical tool that employs an artificial intelligence-based approach to apply techniques of statistical analysis and pattern recognition to quantify the information produced by bone scintigraphy (bone scan) images used to view cancer present in the skeleton. The EXINI Bone BSI tool reads bone scans and produces an automated Bone Scan Index quantification. The Company's clinical-stage products include AZEDRA, 1404 (trofolastat), PyL ([18F] DCFPyL), 1095 and PSMA ADC. The Company's partnered products include Relistor-Subcutaneous injection, Relistor-Oral Tablets and PRO 140.

Industry, Sector and Symbol:

• Sector: Medical
• Industry: Biotechnology
• Sub-Industry: Biotechnology
• Exchange: NASDAQ
• Symbol: PGNX
• CUSIP: 74318710

Key Metrics:

• Previous Close: $6.06
• 50 Day Moving Average: $6.41
• 200 Day Moving Average: $5.30
• 52-Week Range: $3.61 - $8.37
• Trailing P/E Ratio: N/A
• Foreward P/E Ratio: -33.67
• P/E Growth: 0.16
• Market Cap: $424.11M
• Outstanding Shares: 69,985,000
• Beta: 2.34

Profitability:

• Net Margins: -203.56%
• Return on Equity: -41.76%
• Return on Assets: -27.95%

Debt:

• Current Ratio: 5.14%
• Quick Ratio: 5.14%

Additional Links:

• Visit Progenics Pharmaceuticals' Official Website
• View PGNX on Google Finance
• View PGNX on Yahoo Finance
• View PGNX's Company Profile on Reuters
• Search for Progenics Pharmaceuticals Inc. on Google

Companies Related to Progenics Pharmaceuticals:

• Retrophin (NASDAQ:RTRX)
• Global Blood Therapeutics (NASDAQ:GBT)
• Merrimack Pharmaceuticals (NASDAQ:MACK)
• Wave Life Sciences Pte. (NASDAQ:WVE)
• Orthofix International NV (NASDAQ:OFIX)
• U.S. Physical Therapy (NYSE:USPH)
• Raptor Pharmaceutical Corp. (NASDAQ:RPTP)
• Cardiovascular Systems (NASDAQ:CSII)
• ANI Pharmaceuticals (NASDAQ:ANIP)
• NovoCure (NASDAQ:NVCR)

Earnings

Earnings History for Progenics Pharmaceuticals (NASDAQ:PGNX)

Date	Quarter	Consensus Estimate	Actual EPS	Revenue Estimate	Actual Revenue	Release Link	Conference Call	Details
11/7/2016
8/4/2016	Q216	($0.13)	($0.08)	$6.33 million	$8.50 million	View	N/A
5/5/2016	Q116	($0.13)	($0.18)	$3.27 million	$2.50 million	View	Listen
3/11/2016	Q415	($0.14)	($0.10)	$2.25 million	$5.10 million	View	Listen
11/9/2015	Q315	($0.13)	($0.14)	$2.35 million	$1.40 million	View	Listen
8/6/2015	Q215	($0.15)	($0.17)	$1.63 million	$1.90 million	View	Listen
5/6/2015	Q115	($0.16)	($0.15)	$1.30 million	$0.25 million	View	N/A
3/16/2015	Q414	($0.13)	($0.18)	$2.87 million	($0.57) million	View	N/A
11/7/2014	Q314	($0.16)	$0.51	$2.50 million	$41.66 million	View	N/A
8/8/2014	Q214	($0.14)	($0.17)	$2.83 million	$1.50 million	View	Listen
5/9/2014	Q114	($0.15)	($0.15)	$2.88 million	$1.80 million	View	N/A
3/13/2014	Q4	($0.19)	($0.14)	$1.48 million	$3.00 million	View	Listen
11/11/2013	Q313	($0.22)	($0.17)	$2.00 million	$0.90 million	View	N/A
8/9/2013	Q2 2013	($0.24)	($0.24)	$1.86 million	$1.80 million	View	N/A
5/10/2013	Q1 2013	($0.19)	($0.22)	$1.71 million	$2.23 million	View	N/A
3/15/2013	Q4 2012	($0.31)	($0.01)	$1.16 million	$8.87 million	View	N/A
11/8/2012	Q312	($0.30)	($0.33)	$2.52 million	$1.10 million	View	N/A
8/9/2012		($0.32)	($0.32)			View	N/A
5/8/2012		($0.33)	($0.39)			View	N/A
11/9/2011		($0.33)	($0.34)			View	N/A
8/9/2011		($0.25)	$1.64			View	N/A
5/10/2011		($0.51)	($0.69)			View	N/A
3/15/2011		($0.57)	($0.57)			View	N/A

(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Progenics Pharmaceuticals (NASDAQ:PGNX)

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q1 2016	1	($0.12)	($0.12)	($0.12)
Q2 2016	1	($0.11)	($0.11)	($0.11)
Q3 2016	1	$0.52	$0.52	$0.52
Q4 2016	1	($0.14)	($0.14)	($0.14)

(Data provided by Zacks Investment Research)

Dividends

Dividend History for Progenics Pharmaceuticals (NASDAQ:PGNX)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Progenics Pharmaceuticals (NASDAQ:PGNX)

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Details
6/11/2015	Robert J Israel	EVP	Sell	2,000	$6.83	$13,660.00
3/13/2015	Robert J Israel	EVP	Sell	3,000	$7.00	$21,000.00
3/11/2015	Robert J Israel	EVP	Sell	2,000	$6.83	$13,660.00
3/3/2015	Robert J Israel	EVP	Sell	5,000	$6.49	$32,450.00
1/12/2015	Robert J Israel	EVP	Sell	2,000	$7.06	$14,120.00
12/11/2014	Robert J Israel	EVP	Sell	3,000	$7.07	$21,210.00
11/21/2014	Robert J Israel	EVP	Sell	9,000	$7.00	$63,000.00
11/13/2014	Robert J Israel	EVP	Sell	10,000	$6.83	$68,300.00
11/11/2014	Robert J Israel	EVP	Sell	5,000	$6.53	$32,650.00
7/21/2014	Healthcare Master Fun Broadfin	Major Shareholder	Buy	1,625,436	$4.60	$7,477,005.60
7/18/2014	Healthcare Master Fun Broadfin	Major Shareholder	Buy	388,200	$4.73	$1,836,186.00
7/17/2014	Healthcare Master Fun Broadfin	Major Shareholder	Buy	436,884	$4.48	$1,957,240.32
7/16/2014	Healthcare Master Fun Broadfin	Major Shareholder	Buy	411,693	$4.48	$1,844,384.64
7/18/2013	Robert J Israel	VP	Sell	5,000	$6.33	$31,650.00
2/27/2013	Mark Robert Baker	CEO	Buy	1,262	$2.72	$3,432.64
1/22/2013	Mark Robert Baker	CEO	Buy	1,215	$2.82	$3,426.30
12/26/2012	Mark Robert Baker	CEO	Buy	1,142	$3.01	$3,437.42
11/28/2012	Mark Robert Baker	CEO	Buy	1,607	$2.13	$3,422.91
11/19/2012	Mark Robert Baker	CEO	Buy	11,800	$1.96	$23,128.00
11/16/2012	Mark Robert Baker	CEO	Buy	49,793	$1.82	$90,623.26
11/15/2012	Mark Robert Baker	CEO	Buy	48,833	$1.69	$82,527.77
10/24/2012	Mark Robert Baker	CEO	Buy	1,162	$2.96	$3,439.52
9/26/2012	Mark Robert Baker	CEO	Buy	1,036	$3.32	$3,439.52

(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Progenics Pharmaceuticals (NASDAQ:PGNX)

Date	Headline
	News review of 2 biotech stocks: Immunomedics (NASDAQ:IMMU), Progenics Pharmaceuticals (NASDAQ:PGNX) - The Voice Registrar (NASDAQ:PGNX) voiceregistrar.com - September 23 at 11:31 AM
	Progenics Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : PGNX-US : September 23, 2016 (NASDAQ:PGNX) www.capitalcube.com - September 23 at 11:31 AM
	Analysts' Consensus Opinions for: Progenics Pharmaceuticals Inc. (NASDAQ:PGNX) , Sorrento Therapeutics, Inc ... - Wall Street Times (press release) (NASDAQ:PGNX) www.wallstreetnews24.com - September 22 at 6:26 PM
	Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX) earnings expectations - The Independent Republic (NASDAQ:PGNX) theindependentrepublic.com - September 22 at 6:26 PM
	Progenics Pharmaceuticals, Inc. – Value Analysis (NASDAQ:PGNX) : September 14, 2016 (NASDAQ:PGNX) www.capitalcube.com - September 14 at 6:54 PM
	Progenics Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : PGNX-US : September 13, 2016 (NASDAQ:PGNX) www.capitalcube.com - September 13 at 11:39 AM
	Two Biotechnology Names Are Hot: Agenus Inc. (AGEN), Progenics Pharmaceuticals, Inc. (PGNX) - The Independent Republic (NASDAQ:PGNX) theindependentrepublic.com - September 12 at 11:23 AM
	Valeant Pharmaceuticals, Progenics Pharmaceuticals: Commercially Launched FDA Approved Relistor Tablets (NASDAQ:PGNX) larampadinapoli.com - September 9 at 6:22 PM
	The Statistics Don't Lie: Progenics Pharmaceuticals, Incorporated (NASDAQ:PGNX) Earnings Preview - The Voice Registrar (NASDAQ:PGNX) voiceregistrar.com - September 9 at 11:30 AM
	Biotech Companies To Look Out For: Progenics Pharmaceuticals, Inc. (PGNX), Gilead Sciences Inc. (GILD) - National Daily Press (NASDAQ:PGNX) www.nationaldailypress.com - September 9 at 11:30 AM
	Valeant Pharmaceuticals, Progenics Pharmaceuticals: Commercially Launched FDA Approved Relistor Tablets - Bidness ETC (NASDAQ:PGNX) www.bidnessetc.com - September 8 at 10:35 AM
	Progenics Pharmaceuticals Announces Appointment of Bryce V. Tenbarge as Vice President of Commercial - GlobeNewswire (press release) (NASDAQ:PGNX) globenewswire.com - September 7 at 6:53 PM
	News review of 2 biotech stocks: Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX), CTI BioPharma Corp. (NASDAQ ... - The Voice Registrar (NASDAQ:PGNX) voiceregistrar.com - September 7 at 6:53 PM
	Valeant And Progenics Announce U.S. Commercial Launch Of Relistor Tablet (NASDAQ:PGNX) www.rttnews.com - September 7 at 10:18 AM
	Progenics Pharmaceuticals Announces Appointment of Bryce V. Tenbarge as Vice President of Commercial (NASDAQ:PGNX) www.publicnow.com - September 7 at 10:18 AM
	22 Stocks Moving In Wednesday's Pre-Market Session (NASDAQ:PGNX) feeds.benzinga.com - September 7 at 9:19 AM
	Valeant And Progenics Announce The U.S. Commercial Launch Of FDA-Approved Relistor Tablets (NASDAQ:PGNX) www.marketwatch.com - September 6 at 6:53 PM
	Valeant Pharma (VRX), Progenics (PGNX) Announce Commercial Launch of RELISTOR as OIC Treatment (NASDAQ:PGNX) www.streetinsider.com - September 6 at 6:53 PM
	Valeant And Progenics Announce The U.S. Commercial Launch Of FDA-Approved Relistor® Tablets (NASDAQ:PGNX) www.publicnow.com - September 6 at 6:53 PM
	PROGENICS PHARMACEUTICALS INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits (NASDAQ:PGNX) biz.yahoo.com - September 6 at 6:53 PM
	Time To Put On The Watch List? - Progenics Pharmaceuticals (NASDAQ:PGNX), Juno Therapeutics (NASDAQ:JUNO) - The Voice Registrar (NASDAQ:PGNX) voiceregistrar.com - September 6 at 11:32 AM
	Biotech Stocks To Put On Your Watch List: Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX), Chimerix, Inc. (NASDAQ ... - The Voice Registrar (NASDAQ:PGNX) voiceregistrar.com - September 2 at 11:37 AM
	Progenics Pharmaceuticals to Present at the 23rd Annual NewsMakers in the Biotech Industry Conference (NASDAQ:PGNX) www.publicnow.com - September 2 at 11:37 AM
	PROGENICS PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers (NASDAQ:PGNX) biz.yahoo.com - September 1 at 9:54 AM
	Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX) Upcoming ... - The Voice Registrar (NASDAQ:PGNX) voiceregistrar.com - August 30 at 10:06 AM
	News review of 2 biotech stocks: Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX), Biogen Inc. (NASDAQ:BIIB) - The Voice Registrar (NASDAQ:PGNX) voiceregistrar.com - August 29 at 11:20 AM
	Biotech news that matter for investors: Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX), Intrexon Corporation (NYSE ... - The Voice Registrar (NASDAQ:PGNX) voiceregistrar.com - August 26 at 9:46 AM
	Short Interest Increases 10% For PGNX (NASDAQ:PGNX) www.marketnewsvideo.com - August 25 at 6:52 PM
	Progenics Pharmaceuticals Shares Up 19.4% Since SmarTrend's Buy Recommendation (PGNX) (NASDAQ:PGNX) www.mysmartrend.com - August 25 at 11:56 AM
	2 Biotech Stocks News And Price Trends: Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX), Immunomedics Inc ... - The Voice Registrar (NASDAQ:PGNX) voiceregistrar.com - August 19 at 9:50 AM
	4 Breakout Stocks to Watch This Week (NASDAQ:PGNX) www.nasdaq.com - August 18 at 6:59 PM
	Progenics Pharmaceuticals Shares Up 24.3% Since SmarTrend's Buy Recommendation (PGNX) (NASDAQ:PGNX) www.mysmartrend.com - August 17 at 7:05 PM
	The Key Numbers To Watch From Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX)'s Earnings - The Voice Registrar (NASDAQ:PGNX) voiceregistrar.com - August 17 at 9:50 AM
	4 Stocks To Watch: CWEI, EBIO, GIMO, PGNX (NASDAQ:PGNX) www.investing.com - August 16 at 10:04 AM
	PROGENICS PHARMACEUTICALS INC Financials (NASDAQ:PGNX) finance.yahoo.com - August 13 at 6:28 PM
	Progenics Pharmaceuticals Up 21.0% Since SmarTrend Uptrend Call (PGNX) (NASDAQ:PGNX) www.mysmartrend.com - August 10 at 7:17 PM
	Hot Biotech Stocks Recap: Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX), Celgene Corporation (NASDAQ:CELG) - The Voice Registrar (NASDAQ:PGNX) voiceregistrar.com - August 10 at 9:55 AM
	Healthcare Shares Need To Consider: Progenics Pharmaceuticals ... - TWN (NASDAQ:PGNX) thewellesleysnews.com - August 10 at 9:55 AM
	Analysts Actions to Track: Progenics Pharmaceuticals Inc. (NASDAQ:PGNX) , Merck & Company, Inc. (NYSE:MRK) - Street Updates (NASDAQ:PGNX) www.streetupdates.com - August 10 at 9:55 AM
	High Volume Healthcare Stocks: Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX), Bristol-Myers Squibb Company ... - TWN (NASDAQ:PGNX) thewellesleysnews.com - August 10 at 9:55 AM
	Which way Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX) insiders are heading - Review Fortune (NASDAQ:PGNX) reviewfortune.com - August 10 at 9:55 AM
	Most Recent analysts Ratings: Progenics Pharmaceuticals Inc. (NASDAQ:PGNX) - News Oracle (NASDAQ:PGNX) www.newsoracle.com - August 10 at 9:55 AM
	Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX): Power of Chart, We Made 15% Profit In Just 2 Weeks (NASDAQ:PGNX) www.marketnewscall.com - August 9 at 7:04 PM
	Analyst Stock Ratings: Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX), General Electric Company (NYSE:GE) - TWN (NASDAQ:PGNX) thewellesleysnews.com - August 6 at 9:36 AM
	Progenics Pharmaceuticals Inc. (PGNX) Jumps 5.9% on August 05 - Equities.com (NASDAQ:PGNX) www.equities.com - August 6 at 9:36 AM
	Valeant’s Relistor Said to Draw Interest of Potential Buyers (NASDAQ:PGNX) www.bloomberg.com - August 5 at 7:01 PM
	Progenics Pharmaceuticals Announces Second Quarter 2016 Financial and Business Results (NASDAQ:PGNX) globenewswire.com - August 4 at 7:17 PM
	Form 8-K PROGENICS PHARMACEUTICAL For: Aug 04 (NASDAQ:PGNX) www.streetinsider.com - August 4 at 7:17 PM
	Recent Analysts Ratings of Stocks: Novavax, Inc. (NASDAQ:NVAX) , Progenics Pharmaceuticals Inc. (NASDAQ:PGNX) - Street Updates (NASDAQ:PGNX) www.streetupdates.com - August 4 at 10:00 AM
	Progenics reports 2Q loss (NASDAQ:PGNX) sg.finance.yahoo.com - August 4 at 10:00 AM

Social

Progenics Pharmaceuticals (NASDAQ:PGNX) Chart for Wednesday, September, 28, 2016